Unlocking strategic value in Drug Safety for Life Sciences organizations
This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
Agenda
00:00 – Introduction – Dr. Ángel Navarro
09:21 – Unlocking the value of the integrated Approach to Drug Safety – Dr. Antonio Borregón
20:27 – Patient-Centric approacher to Pharmacovigilance – Dr. Richard Habis
30:50 – Conclusions
Here's what you'll learn
A deep dive into the GAMP 5 second edition
What are the drivers of the GAMP 5 second edition and why is there no GAMP 6?
New, updated and removed chapters to the guidenace
Speaker
Yves Dène
CSV Specialist
Expert knowledge in Vigilance
ONE·VIGILANCE, QbD Group’s solution, emphasizes safety as a revenue-generating activity, offering a comprehensive approach with global expertise. We integrate scientific methodologies, proprietary tools, and a team of experts in pharmacovigilance, biopharmacovigilance, and medical devices vigilance.